evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in United States FDA Approves First Generic GLP-1
Pay in 4 interest-free payments of $5.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States FDA Approves First Generic GLP-1](https://assets.technologynetworks.com/production/dynamic/images/content/404308/first-generic-glp-1-for-obesity-gains-fda-approval-404308-960x540.jpg?cb=13503409)
![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States FDA Approves First Generic GLP-1](https://pharmaceutical-journal.com/wp-content/uploads/2025/09/Feature_GLP1.png)
![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States FDA Approves First Generic GLP-1](https://cdn.sanity.io/images/0vv8moc6/patientcare/052b80bee14aa88c8bc23d0d2186358e8982b16f-674x541.jpg)
![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States FDA Approves First Generic GLP-1](https://siamclinicphuket.com/wp-content/uploads/2025/06/weight-loss-pen.webp)







.jpg/:/rs=h:1000,cg:true,m)
















